Home / Applications / Materials / Bio-based Polyurethane Precursors Strain Engineering

Bio-based Polyurethane Precursors Strain Engineering (Diols & Diamines)

Polyurethanes are versatile polymers used in foams, coatings, and elastomers. Their conventional production relies on petrochemical precursors, notably toxic isocyanates and fossil-derived polyols. The industry is facing increasing pressure to transition to safer, sustainable, and bio-based alternatives, such as bio-diols, bio-diamines, and Non-Isocyanate Polyurethane (NIPU) routes.

CD Biosynsis focuses on engineering high-performance microbial cell factories for the synthesis of key bio-precursors, including 1,4-Butanediol (Bio-BDO), 1,3-Propanediol (Bio-PDO), and Hexamethylenediamine (Bio-HMDA). We utilize synthetic biology and metabolic engineering to optimize novel pathways in microbial hosts, enabling the industrial production of sustainable building blocks for next-generation, environmentally friendly polyurethanes.

Get a Quote
Pain Points Solutions Advantages Process FAQ

Pain Points

Developing bio-based precursors for sustainable polyurethanes faces several critical metabolic and process limitations:

  • Low Titer and Yield of Diols: Biosynthesis pathways for diols (like BDO or PDO) often suffer from low carbon yield and end-product inhibition, resulting in high production costs compared to petrochemical standards.
  • Pathway Complexity for Diamines: Diamine production (e.g., HMDA) requires the introduction of long, non-native synthetic pathways involving multiple steps and heterologous enzymes, which are difficult to balance for optimal flux.
  • Cofactor Imbalance: Many reductase steps in diol and diamine synthesis require high levels of cofactors (e.g., NADH or NADPH), and the microbial host often struggles to regenerate these cofactors efficiently, limiting pathway flux.
  • Downstream Toxicity and Recovery: The precursor products (diols, diamines) can be toxic to the host cell at high concentrations, limiting the achievable titer and complicating expensive downstream separation and purification.

Overcoming these challenges requires comprehensive metabolic reprogramming to efficiently channel carbon flux from renewable feedstocks to these specific high-value monomers.

Solutions

CD Biosynsis applies advanced synthetic biology and metabolic engineering to enhance the sustainable production of polyurethane precursors:

Biosynthesis of Bio-BDO and Bio-PDO

We optimize central carbon metabolism and terminal reductase enzymes for high carbon yield and titer of key diol precursors, such as 1,4-Butanediol (BDO) and 1,3-Propanediol (PDO).

Metabolic Engineering for Bio-HMDA

We design and balance multi-step non-natural pathways (e.g., from Lysine) and engineer key aminotransferase and reductase enzymes for efficient biosynthesis of Hexamethylenediamine (HMDA).

Cofactor and Pathway Balance

We engineer native and heterologous pathways to improve the intracellular supply and regeneration of cofactors (NADH/NADPH) to enhance the flux of reductive synthesis steps.

NIPU Precursor Synthesis

We develop strains for the biosynthesis of bio-based cyclic carbonates, enabling the safer and non-toxic synthesis route for Non-Isocyanate Urethanes (NIPU).

This multi-target engineering approach accelerates the realization of high-performance, bio-based polyurethane materials.

Advantages

Choosing CD Biosynsis's Polyurethane Precursor strain engineering service offers the following core value:

Expertise in Long-Chain Monomer Synthesis

We specialize in engineering pathways for C3, C4, and C6 monomers (PDO, BDO, HMDA), crucial for high-performance polyurethane synthesis.

High Productivity and Scalability

Our engineered strains achieve competitive titer and yield using low-cost renewable feedstocks, ensuring economic viability for industrial scale-up.

Sustainable and Toxic-Free Solution

The bio-based approach reduces reliance on fossil fuels and supports the NIPU route, eliminating the use of toxic isocyanates.

Optimized Cofactor Management

Genetic modifications ensure sufficient energy and reducing power supply (NADH/NADPH) to maximize the flux through reductive pathways.

Accelerated Material R&D

We provide high-purity, bio-based monomers essential for validating new sustainable polyurethane formulations.

We are dedicated to providing genetically superior microbial strains to drive the commercial success of the bio-based polymer industry.

Process

CD Biosynsis's Polyurethane Precursor strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:

  • Host Analysis and Pathway Definition: Define target titer, yield, and purity for diol or diamine. Conduct Flux Balance Analysis (FBA) to model carbon distribution and cofactor demand.
  • Technical Solution Design: Formulate the engineering plan, focusing on selecting the most efficient synthetic route (e.g., BDO from succinate, HMDA from lysine) and enzyme optimization.
  • Strain Editing and Construction: Complete the construction of synthetic operons. Use CRISPR or other tools for the precise editing and stable chromosomal integration of the designed pathway and cofactor regeneration systems.
  • Performance Validation Experiments: Conduct fed-batch fermentation experiments, measuring the final concentration (titer) and carbon yield of the target precursor (BDO, PDO, or HMDA) and key byproducts.
  • Result Report Output: Compile a Strain Engineering Experimental Report that includes fermentation kinetics, metabolic flux data, and detailed chemical analysis (GC/HPLC) of the final precursor purity, essential for polymer synthesis validation.

Technical communication is maintained throughout the process, focusing on timely performance feedback and strategic adjustments to the metabolic engineering plan.

Accelerate your Bio-based Precursor R&D and scale-up! CD Biosynsis provides customized strain engineering solutions:

  • Detailed FBA and Synthetic Pathway Report, outlining the most impactful genetic targets for high-yield precursor production.
  • Contracted clients receive consultation on optimizing fermentation conditions and purification strategies to achieve polymer-grade purity.
  • Experimental reports include complete raw data on growth kinetics, carbon conversion efficiency, and final product titer, essential for commercialization.

FAQ (Frequently Asked Questions)

Still have questions?

Contact Us

What is the advantage of NIPU over traditional polyurethane?

NIPU (Non-Isocyanate Polyurethane) is synthesized without the use of toxic isocyanates, making the manufacturing process safer and more environmentally friendly. Our solutions support the bio-based cyclic carbonate route for NIPU synthesis.

What kind of bio-based precursors can you engineer?

We focus on critical polyurethane precursors, including diols (such as 1,4-Butanediol and 1,3-Propanediol) and diamines (such as Hexamethylenediamine), which form the soft and hard segments of the polymer.

How do you deal with cofactor imbalance in reductive pathways?

We employ metabolic engineering to co-express balanced enzymatic cascades, introduce NAD/NADH or NADP/NADPH regenerating enzymes, or modify central metabolism to increase the pool of reducing power available for the synthesis pathway.

How do you ensure the precursor is suitable for polymerization?

We monitor and optimize precursor purity using advanced analytical techniques (GC/HPLC). High purity is critical, and we use genetic strategies to eliminate the formation of contaminants that could interfere with the downstream polymerization reaction.

What is the estimated project timeline for a new precursor?

The timeline varies based on pathway complexity (diol vs. diamine). A complete project, including FBA, pathway editing, enzyme optimization, and fermentation validation, typically requires 18-24 weeks.

0

There is no product in your cart.